<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40600268</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-726X</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions</Title><ISOAbbreviation>Catheter Cardiovasc Interv</ISOAbbreviation></Journal><ArticleTitle>Coronary Rotational Atherectomy Elective Versus Bailout in Patients With Severely Calcified Lesions and Chronic Renal Failure (CRATER) Trial.</ArticleTitle><Pagination><StartPage>1702</StartPage><EndPage>1712</EndPage><MedlinePgn>1702-1712</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ccd.31730</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Plaque modification is crucial for successful stent expansion in calcified coronary lesions. Although rotational atherectomy (RA) improves initial procedural success compared to balloon predilatation, data comparing elective versus bailout RA, particularly in chronic kidney disease (CKD) patients, are scarce.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To perform a cost analysis of elective RA (E-RA) versus bailout RA (B-RA) to treat severely calcified lesions in patients with CKD, comparing procedural material cost and total healthcare cost.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective, multicentre, randomized study compared the costs, safety, and efficacy of E-RA versus B-RA in severely calcified lesions in CKD patients. Participants were randomized 1:1. The primary endpoint was total healthcare cost at 30 days; secondary endpoints included procedural success, stent expansion, and in-hospital complications.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred and twenty-four patients were enrolled (62 per group). The mean age was 77.3&#x2009;&#xb1;&#x2009;8.3 years; 69.4% were male. There were no baseline clinical differences between both treatment arms. Procedural success was similar (B-RA: 95.2% vs. E-RA: 93.6%; p&#x2009;=&#x2009;0.69), but crossover was higher in B-RA (20.9% vs. 4.8%; p&#x2009;=&#x2009;0.014). Procedural complications were more frequent in the elective group (6.5% vs. 22.5%; p&#x2009;=&#x2009;0.04). The B-RA group tended to higher balloon cost (2100.3 vs. 1485.1&#x20ac;; p&#x2009;=&#x2009;0.06), while E-RA had higher burr costs (374.2 vs. 1408.8&#x20ac;; p&#x2009;&lt;&#x2009;0.01) and tended toward higher stent costs (2396.7 vs. 2836.1&#x20ac;; p&#x2009;=&#x2009;0.06). Overall, procedural material costs were higher in E-RA (6676.9 vs. 7683.3&#x20ac;; p&#x2009;=&#x2009;0.02), but total healthcare costs were not significantly different (12569.1 vs. 14879.1&#x20ac;; p&#x2009;=&#x2009;0.09).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Total healthcare costs were comparable between B-RA and E-RA. A substantial number of patients with CKD and severe CAC required crossover from B-RA, highlighting the potential benefit of E-RA. Besides, the high number of complications underscores the need for expert operators.</AbstractText><CopyrightInformation>&#xa9; 2025 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Galeote</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiology Department, La Paz University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3;n de Investigaci&#xf3;n IDIPAZ, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zubiaur</LastName><ForeName>Jon</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4744-4306</Identifier><AffiliationInfo><Affiliation>Cardiology Department, La Paz University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3;n de Investigaci&#xf3;n IDIPAZ, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jurado-Rom&#xe1;n</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6362-7618</Identifier><AffiliationInfo><Affiliation>Cardiology Department, La Paz University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3;n de Investigaci&#xf3;n IDIPAZ, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Portales</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3193-0035</Identifier><AffiliationInfo><Affiliation>Cardiology Department, San Pedro de Alcantara Hospital, C&#xe1;ceres, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romani</LastName><ForeName>Sebasti&#xe1;n</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0003-4563-0209</Identifier><AffiliationInfo><Affiliation>Cardiology Department, Cl&#xed;nico San Carlos University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salinas</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-4040-4029</Identifier><AffiliationInfo><Affiliation>Cardiology Department, Cl&#xed;nico San Carlos University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Tejada</LastName><ForeName>Julio</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiology Department, October Twelve University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subinas</LastName><ForeName>Asier</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Department, Galdakao-Usansolo University Hospital, Basque country, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez</LastName><ForeName>Marcos</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiology Department, Nuestra Se&#xf1;ora de Candelaria University Hospital, Canary Islands, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palazuelos-Molinero</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2864-9832</Identifier><AffiliationInfo><Affiliation>Cardiology Department, La Luz University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flores</LastName><ForeName>Xacobe</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Cardiology Department, University Hospital Complex of A Coru&#xf1;a, Galicia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiology Department, Cl&#xed;nico San Cecilio University Hospital, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Planas</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Department, General University Hospital of Castell&#xf3;n, Castell&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arroyo</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-0695-9381</Identifier><AffiliationInfo><Affiliation>Cardiology Department, Hospital Universitario de Torrevieja, Alicante, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastos</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0882-2573</Identifier><AffiliationInfo><Affiliation>Cardiology Department, University Hospital Complex of Vigo, Galicia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vera-Vera</LastName><ForeName>Silvio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology Department, La Paz University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3;n de Investigaci&#xf3;n IDIPAZ, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Valero</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology Department, La Paz University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3;n de Investigaci&#xf3;n IDIPAZ, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivero Santana</LastName><ForeName>Borja</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Cardiology Department, La Paz University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3;n de Investigaci&#xf3;n IDIPAZ, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tebar</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiology Department, La Paz University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3;n de Investigaci&#xf3;n IDIPAZ, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lvez</LastName><ForeName>Ariana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5200-4650</Identifier><AffiliationInfo><Affiliation>Cardiology Department, La Paz University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3;n de Investigaci&#xf3;n IDIPAZ, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Ra&#xfa;l</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiology Department, La Paz University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3;n de Investigaci&#xf3;n IDIPAZ, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>The CRATER trial was supported by a nonrestricted grant from Boston Scientific. The Spanish Society of Cardiology was the promoter of the study.</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Catheter Cardiovasc Interv</MedlineTA><NlmUniqueID>100884139</NlmUniqueID><ISSNLinking>1522-1946</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017225" MajorTopicYN="Y">Atherectomy, Coronary</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061205" MajorTopicYN="Y">Vascular Calcification</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017721" MajorTopicYN="N">Hospital Costs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="Y">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic kidney disease</Keyword><Keyword MajorTopicYN="N">intravascular ultrasound</Keyword><Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword><Keyword MajorTopicYN="N">rotational atherectomy</Keyword><Keyword MajorTopicYN="N">severely calcified coronary lesions</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>5</Day><Hour>12</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>2</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40600268</ArticleId><ArticleId IdType="doi">10.1002/ccd.31730</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>H. Kawashima, P. W. Serruys, H. Hara, et al., &#x201c;10&#x2010;Year All&#x2010;Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification,&#x201d; JACC: Cardiovascular Interventions 15, no. 2 (January 2022): 193&#x2013;204.</Citation></Reference><Reference><Citation>S. Jia, J. Li, C. Zhang, et al., &#x201c;Long&#x2010;Term Prognosis of Moderate to Severe Coronary Artery Calcification in Patients Undergoing Percutaneous Coronary Intervention,&#x201d; Circulation Journal 85, no. 1 (December 2020): 50&#x2013;58.</Citation></Reference><Reference><Citation>C. V. Bourantas, Y. J. Zhang, S. Garg, et al., &#x201c;Prognostic Implications of Coronary Calcification in Patients With Obstructive Coronary Artery Disease Treated by Percutaneous Coronary Intervention: A Patient&#x2010;Level Pooled Analysis of 7 Contemporary Stent Trials,&#x201d; Heart 100, no. 15 (August 2014): 1158&#x2013;1164.</Citation></Reference><Reference><Citation>S. M. Moe and N. X. Chen, &#x201c;Pathophysiology of Vascular Calcification in Chronic Kidney Disease,&#x201d; Circulation Research 95, no. 6 (September 2004): 560&#x2013;567.</Citation></Reference><Reference><Citation>Y. Fang, C. Ginsberg, T. Sugatani, M. C. Monier&#x2010;Faugere, H. Malluche, and K. A. Hruska, &#x201c;Early Chronic Kidney Disease&#x2010;Mineral Bone Disorder Stimulates Vascular Calcification,&#x201d; Kidney International 85, no. 1 (January 2014): 142&#x2013;150.</Citation></Reference><Reference><Citation>B. R. Kestenbaum, K. L. Adeney, I. H. de Boer, J. H. Ix, M. G. Shlipak, and D. S. Siscovick, &#x201c;Incidence and Progression of Coronary Calcification in Chronic Kidney Disease: The Multi&#x2010;Ethnic Study of Atherosclerosis,&#x201d; Kidney International 76, no. 9 (November 2009): 991&#x2013;998.</Citation></Reference><Reference><Citation>M. J. Budoff, D. J. Rader, M. P. Reilly, et al., &#x201c;Relationship of Estimated GFR and Coronary Artery Calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study,&#x201d; American Journal of Kidney Diseases 58, no. 4 (October 2011): 519&#x2013;526.</Citation></Reference><Reference><Citation>X. R. Wang, J. J. Zhang, X. X. Xu, and Y. G. Wu, &#x201c;Prevalence of Coronary Artery Calcification and Its Association With Mortality, Cardiovascular Events in Patients With Chronic Kidney Disease: A Systematic Review and Meta&#x2010;Analysis,&#x201d; Renal Failure 41, no. 1 (April 2019): 244&#x2013;256.</Citation></Reference><Reference><Citation>A. Jurado&#x2010;Rom&#xe1;n, A. G&#xf3;mez&#x2010;Menchero, B. Rivero&#x2010;Santana, et al., &#x201c;Rotational Atherectomy, Lithotripsy, or Laser for Calcified Coronary Stenosis,&#x201d; JACC: Cardiovascular Interventions 18, no. 5 (March 2025): 606&#x2013;618.</Citation></Reference><Reference><Citation>M. Abdel&#x2010;Wahab, R. Toelg, R. A. Byrne, et al., &#x201c;High&#x2010;Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug&#x2010;Eluting Stent Implantation in Severely Calcified Coronary Lesions,&#x201d; Circulation: Cardiovascular Interventions 11, no. 10 (October 2018): e007415.</Citation></Reference><Reference><Citation>M. Abdel&#x2010;Wahab, G. Richardt, H. Joachim B&#xfc;ttner, et al., &#x201c;High&#x2010;Speed Rotational Atherectomy Before Paclitaxel&#x2010;Eluting Stent Implantation in Complex Calcified Coronary Lesions,&#x201d; JACC: Cardiovascular Interventions 6, no. 1 (January 2013): 10&#x2013;19.</Citation></Reference><Reference><Citation>L. A. Guzman, C. Simpfendorfer, J. Fix, I. Franco, and P. L. Whitlow, &#x201c;Comparison of Costs of New Atherectomy Devices and Balloon Angioplasty for Coronary Artery Disease,&#x201d; American Journal of Cardiology 74, no. 1 (July 1994): 22&#x2013;25.</Citation></Reference><Reference><Citation>F. J. Neumann, M. Sousa&#x2010;Uva, A. Ahlsson, et al., &#x201c;2018 ESC/EACTS Guidelines on Myocardial Revascularization,&#x201d; European Heart Journal 40, no. 2 (January 2019): 87&#x2013;165.</Citation></Reference><Reference><Citation>D. Dash, &#x201c;Complications of Coronary Intervention: Abrupt Closure, Dissection, Perforation,&#x201d; Heart Asia 5, no. 1 (May 2013): 61&#x2013;65.</Citation></Reference><Reference><Citation>S. G. Ellis, S. Ajluni, A. Z. Arnold, et al., &#x201c;Increased Coronary Perforation in the New Device Era. Incidence, Classification, Management, and Outcome,&#x201d; Circulation 90, no. 6 (December 1994): 2725&#x2013;2730.</Citation></Reference><Reference><Citation>K. Thygesen, J. S. Alpert, A. S. Jaffe, et al., &#x201c;Fourth Universal Definition of Myocardial Infarction (2018),&#x201d; Circulation 138, no. 20 (November 2018): e618&#x2013;e651.</Citation></Reference><Reference><Citation>D. E. Cutlip, S. Windecker, R. Mehran, et al., &#x201c;Clinical End Points in Coronary Stent Trials,&#x201d; Circulation 115, no. 17 (May 2007): 2344&#x2013;2351.</Citation></Reference><Reference><Citation>J. A. Lopes and S. Jorge, &#x201c;The RIFLE and AKIN Classifications for Acute Kidney Injury: A Critical and Comprehensive Review,&#x201d; Clinical Kidney Journal 6, no. 1 (February 2013): 8&#x2013;14.</Citation></Reference><Reference><Citation>C. Farmac&#xe9;uticos CG de, &#x201c;Consejo General de Colegios Farmac&#xe9;uticos [Internet],&#x201d; 2023, https://www.farmaceuticos.com.</Citation></Reference><Reference><Citation>F. Abcha, J. Lemoine, M. Bizot, and M. Amor, &#x201c;Rotational Atherectomy: In Hospital Results of a Real&#x2010;Life Experience for the Treatment of Complex Calcified Coronary Lesions,&#x201d; Archives of Cardiovascular Diseases Supplements 14, no. 1 (January 2022): 22.</Citation></Reference><Reference><Citation>J. Gorol, M. Tajstra, B. Hudzik, A. Lekston, and M. G&#x105;sior, &#x201c;Comparison of Outcomes in Patients Undergoing Rotational Atherectomy After Unsuccessful Coronary Angioplasty Versus Elective Rotational Atherectomy,&#x201d; Advances in Interventional Cardiology 14, no. 2 (2018): 128&#x2013;134.</Citation></Reference><Reference><Citation>W. J. Lo, W. J. Chen, C. H. Lai, et al., &#x201c;Rotablation in Patients With Advanced Renal Insufficiency Through End&#x2010;Stage Renal Disease: Short&#x2010; and Intermediate&#x2010;Term Results,&#x201d; Journal of Interventional Cardiology 2022 (March 2022): 7884401.</Citation></Reference><Reference><Citation>F. Blachutzik, S. Meier, M. Weissner, et al., &#x201c;Coronary Intravascular Lithotripsy and Rotational Atherectomy for Severely Calcified Stenosis: Results From the ROTA.Shock Trial,&#x201d; Catheterization and Cardiovascular Interventions 102, no. 5 (2023): 823&#x2013;833.</Citation></Reference><Reference><Citation>A. Jurado&#x2010;Rom&#xe1;n, A. G&#xf3;mez&#x2010;Menchero, N. Gonzalo, et al., &#x201c;Plaque Modification Techniques to Treat Calcified Coronary Lesions. Position Paper From the ACI&#x2010;SEC,&#x201d; REC: Interventional Cardiology 5 (February 2023): 46&#x2013;61.</Citation></Reference><Reference><Citation>C. S. Dini, G. Nardi, F. Ristalli, A. Mattesini, B. Hamiti, and C. Di Mario, &#x201c;Contemporary Approach to Heavily Calcified Coronary Lesions,&#x201d; Interventional Cardiology Review 14, no. 3 (November 2019): 154&#x2013;163.</Citation></Reference><Reference><Citation>M. B. Protty, S. Gallagher, V. Farooq, et al., &#x201c;Combined Use of Rotational and Excimer LASER Coronary Atherectomy (RASER) During Complex Coronary Angioplasty&#x2014;An Analysis of Cases (2006&#x2013;2016) From the British Cardiovascular Intervention Society Database,&#x201d; Catheterization and Cardiovascular Interventions 97, no. 7 (2021): E911&#x2013;E918.</Citation></Reference><Reference><Citation>A. Jurado&#x2010;Rom&#xe1;n, A. Garc&#xed;a, and R. Moreno, &#x201c;ELCA&#x2010;Tripsy: Combination of Laser and Lithotripsy for Severely Calcified Lesions,&#x201d; Journal of Invasive Cardiology 33, no. 9 (September 2021): E754&#x2013;E755.</Citation></Reference><Reference><Citation>A. Jurado&#x2010;Rom&#xe1;n, A. Gonz&#xe1;lvez, G. Galeote, S. Jim&#xe9;nez&#x2010;Valero, and R. Moreno, &#x201c;RotaTripsy,&#x201d; JACC: Cardiovascular Interventions 12, no. 15 (August 2019): e127&#x2013;e129.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>